Sanofi Likely to Extend $18.5 Billion Tender Offer for Genzyme

20.01.2011 - French drugmaker Sanofi-Aventis is likely to extend its $18.5 billion tender offer for Genzyme one last time as it seeks to buy the U.S. maker of drugs for rare diseases, sources...